1,072
Views
27
CrossRef citations to date
0
Altmetric
Expert Opinion

Management of the COPD Patient with Comorbidities: An Experts Recommendation Document

ORCID Icon, , , ORCID Icon, ORCID Icon &
Pages 1015-1037 | Published online: 07 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mo Yi, Di Jiang, Yuanmin Jia, Wei Xu, Haixia Wang, Yizhang Li, Zeyi Zhang, Jingjing Wang & Ou Chen. (2021) Impact of Caregiving Burden on Quality of Life of Caregivers of COPD Patients: The Chain Mediating Role of Social Support and Negative Coping Styles. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2245-2255.
Read now

Articles from other publishers (26)

Olha Lemko, Diana Reshetar, Svitlana Lukashchuk & Nataliia Vantiukh. (2023) Haloaerosoltherapy and complex recovery treatment based on it as methods of physical rehabilitation for patients with chronic obstructive pulmonary disease. Balneo and PRM Research Journal 14:Vol.14, no.2, pages 561.
Crossref
Safoura SHEIKH REZAEI, Constantin GATTERER, Patrick SULZGRUBER, Felix HOFER, Helene MITTLBOECK, Stefan GAVRILOVIC, Yannick LOYODDIN, Michael WOLZT, Robert SCHÖNBAUER, Walter SPEIDL, Bernhard RICHTER, Gottfried HEINZ & Michael SPONDER. (2023) Risk stratification and long-term outcome of patients receiving in-hospital medical emergency team critical care: experience from Austria's largest medical center. Minerva Medica 114:3.
Crossref
Javier de Miguel-Diez, Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Valentin Hernández-Barrera, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Ricardo Omaña-Palanco, Francisco Javier González-Barcala & Natividad Cuadrado-Corrales. (2023) Trends in prevalence and the effects on hospital outcomes of dementia in patients hospitalized with acute COPD exacerbation. Respiratory Medicine 212, pages 107223.
Crossref
Inae Youn, Jungtae Leem, Moon Joo Cheong, Kwon-Jun Jang, Dae-Young Kim, Beom-Joon Lee, Kwan-Il Kim & Hee-Jae Jung. (2023) Experience of traditional East Asian medicine treatment in patients with chronic obstructive pulmonary disease: A qualitative study protocol. European Journal of Integrative Medicine 60, pages 102248.
Crossref
Anastasia Papaporfyriou, Konstantinos Bartziokas, Daniela Gompelmann, Marco Idzko, Evangelia Fouka, Stavrina Zaneli, Petros Bakakos, Stelios Loukides & Andriana I. Papaioannou. (2023) Cardiovascular Diseases in COPD: From Diagnosis and Prevalence to Therapy. Life 13:6, pages 1299.
Crossref
Carmen Reumkens, Adrian Endres, Sami O. Simons, Paul H.M. Savelkoul, Roy T.M. Sprooten & Frits M.E. Franssen. (2023) Application of the Rome severity classification of COPD exacerbations in a real-world cohort of hospitalised patients. ERJ Open Research 9:3, pages 00569-2022.
Crossref
Sy Duong-Quy, Thu Vo-Pham-Minh, Van Duong-Thi-Thanh, Timothy Craig & Vinh Nguyen-Nhu. (2023) Clinical Approaches to Minimize Readmissions of Patients with COPD: A Narrative Review. Current Respiratory Medicine Reviews 19:1, pages 12-23.
Crossref
Huaizhong Zhang, Yixuan Wang, Heqing Lou, Yanan Zhu, Zongmei Dong, Dong Dong, Peipei Chen, Xuan Zhu, Bi Chen & Pan Zhang. (2023) Prevalence of and factors associated with alexithymia among patients with chronic obstructive pulmonary disease in China: a cross-sectional study. BMC Pulmonary Medicine 23:1.
Crossref
Roberta Queiroz Graumam, Marcelo de Medeiros Pinheiro, Vera Lúcia Szejnfeld, Luis Eduardo Nery & Charlles Heldan de Moura Castro. (2022) High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility. Osteoporosis International 34:1, pages 69-79.
Crossref
Kristin A EvansMichael PollackEdward PortilloCharlie StrangeDaniel R TouchetteAnthony StaresinicSushma PatelJoseph TkaczNorbert Feigler. (2022) Prompt initiation of triple therapy following hospitalization for a chronic obstructive pulmonary disease exacerbation in the United States: An analysis of the PRIMUS study. Journal of Managed Care & Specialty Pharmacy 28:12, pages 1366-1377.
Crossref
Xiao-Fang Li, Cheng-Quan Wan & Yi-Min Mao. (2022) Analysis of pathogenesis and drug treatment of chronic obstructive pulmonary disease complicated with cardiovascular disease. Frontiers in Medicine 9.
Crossref
Abebaw Mengistu Yohannes. (2022) The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 19:10, pages 1638-1639.
Crossref
Stefan D. Anker, Leif-Erik Sander, David H. Fitchett, Bernard Zinman, Anne Pernille Ofstad, Christoph Wanner, Ola Vedin, Sabine Lauer, Subodh Verma, Henry K. Yaggi & Silvio E. Inzucchi. (2022) Empagliflozin in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease. Diabetes Research and Clinical Practice 186, pages 109837.
Crossref
Chin-Ling Li, Mei-Hsin Lin, Yuh-Chyn Tsai, Ching-Wan Tseng, Chia-Ling Chang, Lien-Shi Shen, Ho-Chang Kuo & Shih-Feng Liu. (2022) The Impact of the Age, Dyspnoea, and Airflow Obstruction (ADO) Index on the Medical Burden of Chronic Obstructive Pulmonary Disease (COPD). Journal of Clinical Medicine 11:7, pages 1893.
Crossref
Holly Mitzel, Dakota Brown, Morgan Thomas, Byrne Curl, Mackenzie Wild, Andrea Kelsch, Judge Muskrat, Abulquasem Hossain, Ken Ryan, Olawale Babalola, Madison Burgard & Masfique Mehedi. (2022) Patient-Centered Discussion on End-of-Life Care for Patients with Advanced COPD. Medicina 58:2, pages 254.
Crossref
Sadik HANÇERLİOĞLU, Gülbin KONAKÇI, Orhan ÇAKIR & Fisun ŞENUZUN AYKAR. (2021) Validity and Reliability of Turkish Version of Bristol COPD Knowledge Questionnaire (BCKQTR)/Bristol KOAH Bilgi Düzeyi Soru Formu’nun Türkçe Versiyonunun Geçerlik ve Güvenirliği. Sağlık Akademisi Kastamonu 6:3, pages 172-181.
Crossref
Fabien Latiers, Marie Vandenabeele, William Poncin & Gregory Reychler. (2021) Prevalence and risk factors of musculoskeletal pain in patients with chronic obstructive pulmonary disease: A systematic review. The Clinical Respiratory Journal 15:12, pages 1286-1301.
Crossref
Marte Rystad Øie, Malcolm Sue-Chu, Anne-Sofie Helvik, Sverre Karmhus Steinsvåg, Silje Steinsbekk & Wenche Moe Thorstensen. (2021) Rhinosinusitis without nasal polyps is associated with poorer health-related quality of life in COPD. Respiratory Medicine 189, pages 106661.
Crossref
Alberto Fucarino, Alessandro Pitruzzella, Stefano Burgio, Maria Concetta Zarcone, Domenico Michele Modica, Francesco Cappello & Fabio Bucchieri. (2021) Extracellular Vesicles in Airway Homeostasis and Pathophysiology. Applied Sciences 11:21, pages 9933.
Crossref
Chan-Young Kwon, Boram Lee, Beom-Joon Lee, Kwan-Il Kim & Hee-Jae Jung. (2021) Herbal Medicine Compared to Placebo for Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 12.
Crossref
Christian Muschitz, Ralf Harun Zwick, Judith Haschka, Hans Peter Dimai, Martina Rauner, Karin Amrein, Robert Wakolbinger, Peter Jaksch, Ernst Eber & Peter Pietschmann. (2021) Osteoporose bei pneumologischen ErkrankungenOsteoporosis in pneumological diseases. Wiener klinische Wochenschrift 133:S4, pages 155-173.
Crossref
Yu. A. Sorokina, O. V. Zanozina, E. V. Makarova, S. G. Salcev, G. N. Varvarina & L. V. Lovtsova. (2021) Leptin and its receptor gene polymorphism as a target for pharmacotherapy in T2DM and COPD. Meditsinskiy sovet = Medical Council:7, pages 88-94.
Crossref
Ankita Adhia. (2021) Anxious? Don’t Forget… So Is Grandpa. The Senior Care Pharmacist 36:5, pages 226-227.
Crossref
N. A. Karoli, A. V. Borodkin & A. P. Rebrov. (2021) The use of beta-blockers in patients with chronic obstructive pulmonary disease and chronic heart failure in real clinical practice. South Russian Journal of Therapeutic Practice 2:1, pages 70-75.
Crossref
Belaid Bouazza, Dihia Hadj-Said, Karen A. Pescatore & Rachid Chahed. (2021) Are Patients with Asthma and Chronic Obstructive Pulmonary Disease Preferred Targets of COVID-19?. Tuberculosis and Respiratory Diseases 84:1, pages 22-34.
Crossref
Natalia Vasylivna Chernetska, Hanna Yaroslavivna Stupnytska & Oleksandr Ivanovich Fediv. (2020) The Role of MDR1 (C3435T) Gene Polymorphism in Patients with Chronic Obstructive Pulmonary Disease Associated with Type 2 Diabetes Mellitus. Journal of Medicine and Life 13:3, pages 349-355.
Crossref